Outlook Therapeutics, Inc. (OTLK)

CIK 1649989 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Outlook Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 2, 202640002074701-26-000005
Sep 2, 202630002074701-26-000003
Aug 27, 20268-K0001104659-26-102446
Aug 19, 2026SCHEDULE 13G0001649553-26-000111
Aug 18, 202610-Q0001104659-26-098415
Aug 17, 2026NT 10-Q0001104659-26-097838
Aug 14, 20268-K0001104659-26-096478
Aug 14, 2026424B50001104659-26-096504
Aug 14, 202640001649989-26-000009
Aug 14, 20268-K0001104659-26-096510
Aug 14, 202640001104659-26-097406
Aug 14, 2026SCHEDULE 13D/A0000899140-26-000895
Aug 14, 202640000899140-26-000894
Aug 12, 2026424B50001104659-26-094970
Aug 12, 20268-K0001104659-26-094848
Jul 29, 202640001649989-26-000008
Jul 24, 20268-K0001104659-26-086406
Jul 24, 20268-K0001104659-26-086685
Jul 23, 202640001649989-26-000006
Jul 23, 202640001649989-26-000007
Jul 21, 2026EFFECT9999999995-26-002376
Jul 21, 2026424B30001104659-26-085430
Jul 17, 2026S-30001104659-26-084621
Jul 16, 20268-K0001104659-26-084242
Jul 10, 2026DEFA14A0001104659-26-082361